The evolution of insulin therapy: innovations, challenges, and future prospects is reshaping diabetes management, offering improved formulations and delivery systems. Ultra-rapid and ultra-long-acting insulins provide greater flexibility, reducing the risk of hypoglycemia while optimizing glucose control. Smart insulin pens and continuous glucose monitoring integration enhance precision in dosing. However, challenges such as cost, adherence, and weight gain remain significant barriers to widespread adoption. Research is advancing toward glucose-responsive insulins and implantable delivery systems that mimic pancreatic function. As personalized medicine continues to drive innovation, novel insulin analogs and alternative routes of administration, including oral and inhaled formulations, hold promise for the future of diabetes treatment.
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre diabetes and type 2) with integrative medicine
F Buck Willis, Christian College of Medicine, Belize
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : AI receptor binding studies reveal GPR146 conformational states across diabetic phenotypes: Analysis of C peptide and insulin interactions in cholesterol metabolism cortisol regulation and the vitamin D renin angiotensin axis
David Petch, utR Biotech, Canada
Title : Comparative outcomes of antihypertensive therapy in black vs non hispanic white patients with hypertension and cardiovascular disease
Anil Harrison, Midwestern University, United States